Arndt Vogel, Head of the Visceral Oncology Center, Head of the Center for Personalized Medicine, MHH, and Senior Consultant of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School, shared a post on X:
“Hot off the press: ESMO-MCBS 2.0 Scorecards now available. Do you agree with the proposed benefit? Check them out for Hepatocellular Carcinoma.”
More posts featuring Arndt Vogel on OncoDaily.